INVO Fertility (IVF) EBIT Margin Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28,415.00 |
| Jun 30, 2025 | 27,152.00 |
| Mar 31, 2025 | -50,484.00 |
| Dec 31, 2024 | 38,865.00 |
| Sep 30, 2024 | 11,757.00 |
| Jun 30, 2024 | -9,090.00 |
| Mar 31, 2024 | 8,862.00 |
| Dec 31, 2023 | 22,211.00 |
| Sep 30, 2023 | 6,095.00 |
| Jun 30, 2023 | 97,058.00 |
| Mar 31, 2023 | -52,801.00 |
| Dec 31, 2022 | 229,344.00 |
| Sep 30, 2022 | -86,166.00 |
| Jun 30, 2022 | -167,033.00 |
| Mar 31, 2022 | -134,201.00 |
| Dec 31, 2021 | 298,304.00 |
| Sep 30, 2021 | 12,416.00 |
| Jun 30, 2021 | 2.58 Mn |
| Mar 31, 2021 | 76,989.00 |
| Sep 30, 2020 | 434,875.00 |
| Jun 30, 2020 | 150,355.00 |
| Mar 31, 2020 | 309,696.00 |
| Sep 30, 2019 | 199,384.00 |
| Jun 30, 2019 | 802,997.00 |
| Mar 31, 2019 | 89,576.00 |
| Dec 31, 2018 | 60,752.00 |
| Sep 30, 2018 | 4.17 Mn |
| Jun 30, 2018 | 251,073.00 |
| Mar 31, 2018 | 217,828.00 |
| Dec 31, 2017 | 15,898.00 |
| Sep 30, 2017 | 421,249.00 |
| Jun 30, 2017 | 109,771.00 |
| Mar 31, 2017 | 71,311.00 |
| Dec 31, 2016 | 119,635.00 |
| Sep 30, 2016 | 17,641.00 |
| Jun 30, 2016 | -2.57 Mn |